Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer
about
Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Panitumumab, Cisplatin, and Pe ...... , or Stage III Cervical Cancer
@en
Panitumumab, Cisplatin, and Pe ...... , or Stage III Cervical Cancer
@nl
type
label
Panitumumab, Cisplatin, and Pe ...... , or Stage III Cervical Cancer
@en
Panitumumab, Cisplatin, and Pe ...... , or Stage III Cervical Cancer
@nl
prefLabel
Panitumumab, Cisplatin, and Pe ...... , or Stage III Cervical Cancer
@en
Panitumumab, Cisplatin, and Pe ...... , or Stage III Cervical Cancer
@nl
P3098
NCT01158248